APLD
$16.68 at the check
SHORT

Kairon's answer on APLD: leaning down.

Checked Nov 11, 2026 at $16.68, time frame 3-6 months, confidence high
Why? For, against, what would change it
  • ForRevenue grew 167% last year and is expected to increase by 101%, showing strong product demand and large market expansion.
  • AgainstThe company lost $244M this year, burned $2.78B cash, and has a -53% net income margin with no proven turnaround.
  • What would change the pictureIf revenue growth falls below 50% YoY or if price closes below $14.20, the chance for recovery decreases.
Result check on May 10, 2027: open.

The 10-second check

Loading filings…

Both sides

More for

Such extreme topline acceleration—+167% actual and +101% consensus forward—demonstrates clear product-market fit and rapid addressable market expansion.

Net buying by top officers during price weakness, especially at this scale and synchrony, suggests management conviction that the market undervalues near-term progress or catalysts.

More against

APLD is structurally unprofitable, burning cash at a rate of -$2.78B per year, with no evidence of margin inflection.

Extremely high leverage reduces strategic flexibility, amplifies bankruptcy risk, and may force unfavorable refinancing or asset sales as rates rise or capital markets tighten.

Read the full debate between the bull and the bear analyst

Bull Analyst: BULL CASE ARGUMENTS

---

Argument 1 – Category: Growth [HIGH conviction]
Evidence: Revenue growth +167% YoY (to $611M in 2026), with *analyst consensus for next fiscal year at +101%* topline.
Thesis: Such extreme topline acceleration—+167% actual and +101% consensus forward—demonstrates clear product-market fit and rapid addressable market expansion. While losses are material, this level of scaling is rare and positions APLD for operating leverage if cost controls or margins improve. *Empirically, companies sustaining >100% YoY growth at scale often become multi-year compounders post-turnaround.*

---

Argument 2 – Category: Insider Activity [MEDIUM conviction, per Kairon Radar requirement]
Evidence: 2 insider (CEO, President) *purchases totaling $6.7M* (last 90d, vs only $682K sales), per official Form 4s, with Kairon Radar tilt BULLISH (signal strength 23/100).
Thesis: Net buying by top officers during price weakness, especially at this scale and synchrony, suggests management conviction that the market undervalues near-term progress or catalysts. Kairon historicals show this isn't a timing tool, but statistically, such patterns offer modest upside bias over the next month.

---

Argument 3 – Category: Mean-Reversion/Quant Short Squeeze [MEDIUM conviction]
Evidence: *Short interest 22.4%*, Quant engine: *short-term mean reversion signals at +85 (short_term_reversal), +99 (mc_drift), and +99 (value_meanrev_proxy)*; *Monte Carlo expected return +9.94% mean, +1.80% median, with a 52% up-probability over 21d*.
Thesis: With extremely high short interest and quant/volatility regime statistically favoring mean reversion (recent drawdown -66.4%), probability of a near-term bounce is elevated. If any positive catalyst (earnings surprise, contract win, etc) emerges, the risk-reward can flip rapidly towards the upside via forced short covering. This is not a trend-following setup but a calculated mean reversion play, size-adjusted for realized 128% vol.

---

BEAR COUNTER-ARGUMENTS

---

- Bear said: Lack of profitability (-$244M net loss, -53% margin, -2.78B FCF, negative ROE).
Counter: True, but current consensus reflects these losses, and the rapid revenue scaling (+167% actual, +101% forward) is of a class that frequently precedes margin expansion in scaling tech/infra businesses. EPS surprise trend: *positive beats in 3 of last 4 quarters*, always losses, but often smaller than feared (+1c, +9c, +4c, -1c vs. negative estimates). This pattern shows execution risk narrowing and actual cash burn potentially peaking.

- Bear said: Heavy dilution (+184.5% in 3y, per-share value erosion).
Counter: Dilution has been severe, but with a *current ratio of 2.56 and $1.59B cash (Q2 2026)*, further near-term dilution is less likely. Insider buying post-dilution ($6.7M) signals management sees new float and current price as attractive for longer-term accretion.

- Bear said: Extremely high leverage (Debt/Equity 170.6, net debt $3.38B, reduced flexibility).
Counter: High. However, *current ratio (2.56) and substantial cash ($1.59B) at Q2 2026 close* provide a near-term liquidity buffer. Revenue growth can re-rate debt ratios rapidly if operating leverage emerges. Thus, while structurally risky, risk of near-term default or liquidity crisis is mitigated.

- Bear said: Estimate cuts and very wide analyst target range (low sell-side conviction).
Counter: Consensus targets average *$59.94* (high $93, low $22), which gives a 3.6x upside to mean, underscoring not just risk but perceived potential. While estimate cuts are a flag, the wide range also reflects sensitivity to high-growth inflections—if company delivers a modest margin beat or new contract, targets could converge upwards quickly, especially with a high short base forced to cover.

- Bear said: Downtrend, negative momentum, poor technicals, high realized vol.
Counter: Quant engine and technical regime are structurally bearish, but *mean-reversion* signals are strongly positive (z-score +40, short_term_reversal +85, value_meanrev_proxy +99). With *current drawdown at -66.4%* and volatility regime mean-reverting, historic statistical odds for a sharp rebound are higher now than during trend phases, especially if mean reversion aligns with fundamental or news catalysts.

---

BULL THESIS INVALIDATION LEVEL
The bull thesis breaks if:
- Revenue growth falls below 50% YoY in the next report (i.e., topline deceleration signals stall in addressable market capture),
- Or, price closes below $14.20 (well through Bollinger lower band/support), signaling technical breakdown and no bounce despite deeply oversold conditions.

---

OVERALL BULL CONVICTION: LOW (3/10)
Justification:
- Only one HIGH conviction (empirical, outsized revenue growth); two MEDIUM (insider buys per Kairon, mean-reversion/short squeeze potential).
- Technical/chart and quant regime are actively bearish, not supportive for strong long conviction outside a tactical oversold play.
- Key risks—leverage, dilution, negative profit/cash flow—are real and acknowledged; any fundamental turnaround is unproven.
- Without a sustained reversal or positive fundamental surprise, bull case is constrained to oversold-bounce probability, not a structural long.

*In summary: short-term bounce potential is real (mean reversion, insider conviction, short squeeze setup), but structurally the bull case requires more execution and evidence before high conviction is warranted.*
Bear Analyst: BEAR CASE RISKS

---

Risk 1 – Category: Fundamental (Profitability & Cash Flow) [HIGH conviction]
Evidence: Net Loss of -$244M (2026); Net Income Margin -53.0%; Free Cash Flow (TTM) -$2.78B; ROE -13.6%.
Risk: APLD is structurally unprofitable, burning cash at a rate of -$2.78B per year, with no evidence of margin inflection. Negative EBITDA and deeply negative margins imply ongoing value destruction. If this persists, further capital raises and dilution are likely, and compounding losses threaten financial sustainability.
Quantified downside: Historically, stocks with persistent negative FCF and margin contraction >40% trade down an additional 35–50% from current levels as market discounts terminal risk.

---

Risk 2 – Category: Fundamental (Balance Sheet/Leverage) [HIGH conviction]
Evidence: Debt/Equity 170.6; Net Debt $3.38B (2026); Current Ratio 2.56 (with $1.59B cash, but cash burn rate exceeds working capital).
Risk: Extremely high leverage reduces strategic flexibility, amplifies bankruptcy risk, and may force unfavorable refinancing or asset sales as rates rise or capital markets tighten. With annual FCF negative (-$2.78B vs $1.59B cash), runway is less than 1 year at current burn.
Quantified downside: If liquidity deteriorates or debt covenants breach, equity typically reprices 40–60% lower, in-line with peer insolvency events (see historical examples: Core Scientific - pre-bankruptcy, -67%).

---

Risk 3 – Category: Fundamental (Dilution/Earnings Quality) [HIGH conviction]
Evidence: Shares outstanding up +184.5% (106M to 302M in three years); ongoing estimate cuts (FY27 EPS -0.784, down from -0.25 in 90 days); no consecutive positive earnings.
Risk: Dilution at this rate means per-share value is eroding far faster than revenue growth; shareholder returns are evaporating. Estimate cuts signal analysts have less faith in forward margin improvement, despite topline expansion, meaning operational execution is not translating into economic value.
Quantified downside: For companies with >100% dilution and negative EPS surprises, historical drawdowns of 45–70% are typical until capital dynamics stabilize (see: Plug Power 2023/24: -60% after >100% dilution, ongoing losses).

---

Risk 4 – Category: Technical (Price Action/Momentum/Volatility) [MEDIUM conviction]
Evidence: Stock trades -45.6% below 200MA ($16.68 vs $30.64); -26.1% below 50MA; RSI 40.98; MACD -1.96; Drawdown -66.4% (1y); Annualized vol 128.25%; Max drawdown -71.46%.
Risk: APLD is in a persistent, deep downtrend with high realized volatility and weak momentum. Technical setup indicates fragile support (Bollinger lower band: $14.58), high risk of further breakdown. Bearish signals dominate; any bounce would be short-lived unless supported by structural improvement.
Quantified downside: Technical breakdown through $14.20 (stop-loss ref) projects an additional 15–25% fall, in line with recent breakouts under lower Bollinger band for high-volatility names.

---

Risk 5 – Category: Analyst Conviction/Sell-Side Uncertainty [MEDIUM conviction]
Evidence: Analyst target dispersion: range $22–$93 (spread is 118.5% of mean); consensus targets cut (median $59.94, current price $16.68 = 72% discount); EPS estimates reduced for FY27 from -0.25 to -0.784 in 90 days.
Risk: The extreme spread in targets and ongoing estimate cuts signal dramatically low conviction among analysts, not just for upside but for business viability. In periods of uncertainty/drawdown, equity tends to "hunt" lows and ignore bullish targets until consensus improves.
Quantified downside: In other sectors with wide dispersion (>100% of mean), prices can trade at the low end of the analyst range ($22, from current $16.68 = +32%), but prolonged uncertainty allows for trading well below the lowest target (see: Nikola Motors 2022–23 −80% below low targets). Fair downside risk: 20–35% additional loss until clarity emerges.

---

BULL COUNTER-ARGUMENTS

---

Bull said: Growth—Revenue +167% YoY, +101% forward, signals product-market fit and margin inflection potential.
Counter: Despite +167% revenue growth, net loss expanded to -$244M (margin -53%), FCF worsened to -$2.78B, and share dilution was +184.5%. Historical evidence shows that in capital-intensive, loss-making infra/tech companies, revenue growth without margin improvement often leads to further stock declines, especially with high dilution and leverage (see: SunPower 2021–24, +120% revenue, persistent losses, -70% share price).

---

Bull said: Insider buying ($6.7M, CEO/President, net positive) signals management conviction.
Counter: Kairon Radar signal strength is only 23/100, meaning statistical upside bias (mean excess return: -5.03%) is weak and not timing-driven. Prior cases: only 37.4% outperformed the market over 20 days. Insider buys in other loss-making, high-dilution firms (Ginkgo Bioworks 2022–23) did not reverse structural drawdowns. No evidence of sustained price improvement from this scale of buying at similar firms.

---

Bull said: Short interest (22.4%), mean-reversion quant signals (short_term_reversal +85, mc_drift +99), Monte Carlo forecasts (+9.94% mean, +1.8% median, 52% up probability) support bounce potential.
Counter: While short squeeze setups can cause volatility, realized annualized vol is 128.25% and drawdown is -66.4%, meaning risk of further downside is almost equal to upside. 21d Monte Carlo median return is only +1.80%, and 5th–95th percentile range (-44.16% to +91.03%) is extremely wide. The regime is mean-reverting but with a 0.01 probability of bull regime—any bounce is probabilistically weak; trend/momentum overwhelmingly argues against sustained recovery.

---

Bull said: EPS beats (vs negative estimates) show execution risk narrowing.
Counter: All beats are versus negative EPS: 2026-05 (+4c vs -19c est), 2026-02 (+9c vs -21c est), but actual net loss and FCF both worsened. Estimate cuts for FY27 from -0.25 to -0.784 (90 days) suggest execution risk is growing, not narrowing.

---

RED FLAGS FROM ANALYST REPORTS

---

- Negative FCF: -$2.78B (TTM, 2026)
- Net income margin: -53.0% (deeply negative)
- Share dilution: +184.5% in 3 years (destroying per-share value)
- Debt/Equity: 170.6 (financial risk extreme)
- ROE: -13.6% (value destruction)
- Analyst estimate cuts for FY27 (−0.25 ➔ −0.784 EPS in 90 days)
- Max Drawdown: -71.46% in 1 year
- Short interest: 22.4% (could fuel volatility, but not upside alone)
- Wide target range: $22 ➔ $93 (spread = 118.5% of mean, reflects uncertainty)

---

BEAR THESIS CONFIRMATION SIGNAL

---

The bear thesis accelerates if:
- Price breaks below key support at $14.20 (stop-loss reference), confirming technical breakdown and further downside in deep trend regime.
- Free Cash Flow remains negative >$2B in next quarter OR net cash position drops below $1B (Q2 2026 at $1.59B), forcing equity raise and new dilution.
- Analyst consensus for revenue growth drops below +50% YoY in the next report, signaling addressable market stall.

---

OVERALL BEAR CONVICTION: HIGH (9/10)

Justification:
- All fundamental and technical signals are deeply negative: chronic losses, extreme dilution, high leverage, and worsening analyst forecasts.
- Multiple HIGH conviction risks, each supported by specific evidence, with downside quantified.
- Market regime is NEUTRAL, not a tailwind, and technicals/quant regime are confirmed bearish (trend/momentum scores all -100/-99, quant conviction 73%).
- No red flags are offset by insider activity or mean-reversion signals—statistical odds of bounce are outweighed by structural risk and tail volatility.
- Volatility is extreme and support is fragile; any bounce is highly speculative and short-lived unless accompanied by true margin/profit turnaround.

Summary: Bear case is structurally dominant; avoid or short until firm evidence of margin, FCF, and technical recovery. High risk of further 30–60% downside if bear thesis triggers.

Want a fresh check?

A new AI check reads today's prices, news and filings. Compact check: one per month free with an account, ready in a few minutes. Full check with every analyst and chart technicals: in a plan or €3.99 once, about 10 minutes.

Start a new AI checkCheck your own entry (free)

Kairon's record on APLD

1 past checks: 1 directional calls (1 right, 0 wrong). Measured by price since each check, no costs. How we measure. Every 'not now' answer.

Nov 11, 2026: Short at $16.68, −31.1 % sinceright

Insider and Congress filings

Loading…

Official SEC Form 4 and House PTR filings. Returns run from the first close after a filing became public. A filing is a fact, not a recommendation.

Full report (technical terms)

Key levels

Support$14.58
Resistance$17.29
Horizon3-6 months
Quant score-34/100

Executive summary

APLD is in a deep structural downtrend, trading 45% below its 200MA with overwhelmingly bearish technical and fundamental signals. Despite mean-reversion and Monte Carlo data suggesting bounce potential, risk/reward is acutely negative (0.25:1), conviction is extremely low (2/10), and all scenario-weighted expected value and Kelly calculations are negative. Portfolio management rules dictate a hard PASS until technical and/or fundamental conditions materially improve.

Investment thesis

All analyst, quant, and risk manager reports unequivocally recommend PASS due to structurally negative technicals (-45% below 200MA), weak fundamentals (deep losses, high debt/dilution), and unattractive risk/reward ratios (0.25:1). The base and tail risk scenarios dominate—downside continuation (-12% to -30%) is far more probable than any upside bounce. Insider/radar tilt, while modestly bullish, carries insufficient statistical weight; historical edge is negative. Mean-reversion signals and Monte Carlo projections do not outweigh overwhelmingly bearish trend/momentum and risk metrics. No setup justifies position sizing; wait for a structural regime shift or fundamental catalyst before reconsidering.

Valuation assessment

APLD trades dramatically below its 1-year high and key moving averages (-45% vs 200MA). Forward P/E is negative, net margin -53%, FCF deeply negative; dilution and leverage are severe. Volatility and drawdown discourage any risk/reward setup. Valuation and technicals strongly favor no position at current levels.

Scenario analysis

Bull case (bounce to $17.29, +3.7%) has only 15% probability; max bull short squeeze (<3%) to $21.86. Bear base scenario ($14.58, -12.6%) is 35%, max bear tail risk ($11.69, -30%) is 10%. Probability-weighted EV is deeply negative; aggressive and conservative risk managers agree no position is justified. Only reconsider after structural improvement or new catalyst.

Key risks

High volatility, structural trend continuation, potential liquidity/funding panic, extreme downside risk (-30%). Stop-loss cannot be defensibly set due to volatility regime (ATR 10.8%). Fundamentals severely negative: high leverage, negative margins, dilution, estimate cuts.

AI-generated. Created 2026-11-11 12:42 UTC automatically by Kairon AI (Cem Salomon Weidner, Vienna, Austria) at a price of $16.68. Valid for its time frame from that moment; it is not updated afterwards. Facts come from public sources (Yahoo Finance and others, partly delayed); the rating, levels and scenarios are opinions of the AI. General information, not investment advice and not a solicitation to buy or sell. Conflicts of interest, methodology and risks: disclosure. Every past call and its outcome: track record.

Open this analysis in the app

More checks

Learn the method

Kairon AI is an automated research and second-opinion tool, not a licensed financial advisor, broker, or investment manager. All assessments are AI-generated opinions based on public data and are informational only — not personal investment advice. Investing carries risk, including total loss of capital.

Impressum Privacy Terms Disclaimer